Cue Biopharma Inc.

CUE | NASDAQ

Price Alert Chart Builder DCF Calculator

$28.27

-$8.78 (-23.70%)

At close: Sep 21, 2026, 4:00 PM ET

$28.77

+$0.50 (+1.77%)

Pre-market: Sep 22, 2026, 9:08 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-23.70%

(1D)

Rating

Updated: Sep 12, 2026

Fundamentals Average

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $74.29M

1D Range

23.80 28.49

52W Range

4.98 45.50

Valuation (TTM)

PE -1.05

PB 32.16

EV/EBITDA -0.63

Valuation (NTM)

Forward PE N/A

Forward PEG 0.01

Price Target $4.33

Cash Flow

FCF Yield -67.5%

SBC Adj. FCF Yield -102.6%

SBC Impact -51.9%

Margins

Gross Margin 99.7%

Operating Margin -262.0%

FCF Margin -133.2%

Growth (CAGR)

Revenue 3Y | 5Y 176.2% | 47.1%

Dil EPS 3Y | 5Y 4.3% | 18.4%

FCF 3Y | 5Y -14.8% | -1.6%

Returns

ROA -534.4%

ROE -1032.2%

ROIC -887.3%

Financial Health

Net Cash

$14.32M

Current Ratio 1.25

Interest Coverage -730.70

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical enterprise focused on creating biological therapies. Its central objective is the precise manipulation of the human immune system to address a...

Sector Healthcare

Industry Biotechnology

Employees 29

IPO Date Jan 1, 2018

Website www.cuebiopharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 12, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞